| Check Point Software Technologies Ltd | 119.8600 / +0.69% |
| Date/Time | 04/21 / 19:38 |
| Chg. / Chg.(%) | 0.8200 / +0.69% |
| Bid | 119.8200 / 100 |
| Ask | 119.8700 / 100 |
| Open | 118.8700 |
| Previous Close | 119.0400 |
| High | 119.9200 |
| Low | 118.4800 |
| Volume [USD] | 63,903,350.4451 |
| Volume [Units] | 706,121 |
| Price fixings | 2455 |
| ISIN | IL0010824113 |
| Security | CHKP |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 119.8600 |  |
706,121 |
| IEX | 119.59 | |
33,672 |
| Cboe US | 119.86 | |
15,245 |
| Stuttgart | 99.180 | |
2,006 |
| TradeGate | 99.400 | |
453 |
| Frankfurt | 99.8400 |  |
50 |
| Hannover | 98.62 | |
0 |
| München | 98.26 | |
0 |
| Berlin | 99.46 | |
0 |
| Hamburg | 98.62 | |
0 |
| Düsseldorf | 99.36 | |
0 |
| Vienna Globa.. | 99.24 | |
0 |
| Lang & Schwa.. | 99.380 | |
|
| gettex | 99.340 | |
|
| London Inter.. | 119.30 | 100 | |
| Mexico | 2,350.00 |  |
156 |
News
- Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom
14:38 - GlobeNewswire - Replimune Appoints Genentech Global Oncology Franchise Head Sushil Patel, Ph.D. as Chief Commercial Officer
14:00 - GlobeNewswire - Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
14:00 - GlobeNewswire - MITRE Engenuity ATT&CK® Evaluations Highlight Check Point Software’s Leadership in Endpoint Security with 100% Detection across All Tested Unique ATT&CK Techniques
04/20/2021 / 19:24 - GlobeNewswire - Y-mAbs Provides Regulatory Update on Omburtamab
04/20/2021 / 15:00 - GlobeNewswire
Real-time